Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha

Applied and Environmental Microbiology

Volumn 65, Issue 10, 1999, Pages 4295-4300

  Theys, J ^a   Nuyts, S ^b   Landuyt, W ^b   Van Mellaert, L ^a   Dillen, C ^a   Bohringer M ^c   Durre P ^c   Lambin, P ^b   Anne J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULASE; COMPLEMENTARY DNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER THERAPY; CLOSTRIDIUM ACETOBUTYLICUM; CONTROLLED STUDY; ESCHERICHIA COLI; GENE TRANSFER; GENETIC RECOMBINATION; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION;

CLOSTRIDIUM ACETOBUTYLICUM; ESCHERICHIA COLI; MURINAE; NEGIBACTERIA; POSIBACTERIA;

EID: 0032830180     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.65.10.4295-4300.1999     Document Type: Article

References (40)

1. Asher, A., J. J. Mulé, C. M. Reichert, E. Shiloni, and S. A. Rosenberg. 1987. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol. 138:963-974.
2. Azzedoug, H., J. Hubert, and G. Reysset. 1992. Stable inheritance of shuttle vectors based on plasmid pIM13 in a mutant strain of Clostridium acetobutylicum. J. Gen. Microbiol. 138:1371-1378.
3. Fiers, W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285:199-212.
4. Fox, M. E., M. J. Lemmon, M. L. Mauchline, T. O. Davis, A. J. Giaccia, N. P. Minton, and J. M. Brown. 1996. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther. 3:173-178.
5. Fransen, L., M. R. Ruysschaert, J. Van Der Heyden, and W. Fiers. 1986. Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. Cell. Immunol. 100:260-267.
6. Hallahan, D. E., H. J. Mauceri, L. P. Seung, E. J. Dunphy, J. D. Wayne, N. D. Hanna, A. Toledano, S. Hellman, D. W. Kufe, and R. R. Weichselbaum. 1995. Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1:786-791.
7. Haranaka, K., N. Satomi, and A. Sakurai. 1984. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int. J. Cancer 34:263-267.
8. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853-1869.
9. Hoeltke, H.-J., S. Schneider, I. Ettl, R. Binsack, I. Obermaier, M. Seller, and G. Sagner. 1995. Rapid, highly sensitive detection of digoxigenin-labeled nucleic acids by improved chemiluminescent alkaline phosphatase substrates. Biochemica (Boehringer) 1:17-20.
10. Kornbluth, A. A., J. B. Danzig, and L. H. Bernstein. 1989. Clostridium septicum infection and associated malignancy. Medicine 68:30-37.
11. Lambin, P., W. Landuyt, J. Theys, S. Nuyts, L. Van Mellaert, and J. Anné. Specific tumor colonization by Clostridium saccharoperbutylacetonicum. Submitted for publication.
12. Lambin, P., J. Theys, W. Landuyt, P. Rijken, A. van der Kogel, E. van der Schueren, R. Hodgkiss, J. Fowler, S. Nuyts, E. de Bruijn, L. Van Mellaert, and J. Anné. 1998. Colonization of Clostridium in the body is restricted to hypoxic and necrotic areas of tumors. Anaerobe 4:183-188.
13. Lammertyn, E., L. Van Mellaert, S. Schacht, C. Dillen, E. Sablon, A. Van Broekhoven, and J. Anné. 1997. Evaluation of a novel subtilisin inhibitor gene and mutant derivatives for the expression and secretion of mouse tumor necrosis factor alpha by Streptomyces lividans. Appl. Environ. Microbiol. 63:1808-1813.
14. Landuyt, W., J. Theys, S. Nuyts, A. Reijnders, J. W. Fowler, W. Van Den Bogaert, L. Van Mellaert, J. Anné, and P. Lambin. Tumor colonisation with anaerobic bacteria following vascular targeting treatment: improvement for bacterial gene therapy developments.
15. Larrick, J. W., and S. C. Wright. 1990. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4:3215-3223.
16. Laster, S. M., J. G. Wood, and L. R. Goodding. 1988. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
17. Lemmon, M. J., P. van Zijl, M. E. Fox, M. L. Mauchline, A. J. Giaccia, N. P. Minton, and J. M. Brown. 1997. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther. 4:791-796.
18. Low, K. B., M. Ittensohn, T. Le, J. Platt, S. Sodi, M. Amoss, O. Ash, E. Carmichael, A. Chakraborty, J. Fisher, S. L. Lin, X. Luo, S. I. Miller, L. M. Zheng, I. King, J. M. Pawelek, and D. Bermudes. 1999. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nature Biotechnol. 17:37-41.
19. Malmgren, R. A., and C. C. Flanigan. 1955. Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res. 15:473-478.
20. Mauchline, M. L., T. Davis, and N. P. Minton. 1999. Clostridia, p. 475-490. In A. L. Demain and J. E. Davies (ed.), Manual of industrial microbiology and biotechnology. Blackwell Science, Oxford United Kingdom.
21. Mermelstein, L. D., N. E. Welker, G. N. Bennett, and E. T. Papoutsakis. 1992. Expression of cloned homologous fermentative genes in Clostridium acetobutylicum ATCC 824. Bio/Technology 10:190-195.
22. Mermelstein, L. D., and E. T. Papoutsakis. 1993. In vivo methylation in Escherichia coli by the Bacillus subtilis phage φ3T I methyltransferase to protect plasmids from restriction upon transformation of Clostridium acetobutylicum ATCC824. Appl. Environ. Microbiol. 59:1077-1081.
23. Minton, N. P., and J. D. Oultram. 1988. Host:vector systems for gene cloning in Clostridium. Microbiol. Sci. 5:310-315.
24. Minton, N. P., M. L. Mauchline, M. J. Lemmon, J. K. Brehm, M. Fox, N. P. Michael, A. Giaccia, and J. M. Brown. 1995. Chemotherapeutic tumor targeting using clostridial spores. FEMS Microbiol. Rev. 17:357-364.
25. Nakotte, S., S. Schaffer, M. Böhringer, and P. Dürre. 1998. Electroporation of plasmid isolation from and plasmid conservation in Clostridium acetobutylicum DSM792. Appl. Microbiol. Biotechnol. 50:564-567.
26. Oultram, J. D., M. Loughlin, T. J. Swinfield, J. K. Brehm, D. E. Thompson, and N. P. Minton. 1988. Introduction of plasmids into whole cells of Clostridium acetobutylicum by electroporation. FEMS Microbiol. Lett. 56:83-88.
27. Pawelek, J. M., K. B. Low, and D. Bermudes. 1997. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57:4537-4544.
28. Raijinder, S. S., and A. P. Bollon. 1993. Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol. Ther. 57:79-128.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Schiller, J. H., B. E. Storer, P. L. Witt, D. Alberti, M. B. Tombes, R. Arzoomanian, R. A. Proctor, D. McCarthy, R. R. Brown, S. D. Voss, S. C. Remick, J. L. Grem, E. C. Borden, and D. L. Trump. 1991. Biological and clinical effects of intravenous tumor necrosis factor α administered three times weekly. Cancer Res. 51:1651-1658.
31. Sersa, G., V. Willingham, and L. Milas. 1988. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy. Int. J. Cancer 42:129-134.
32. Sjöstedt, J., L. Kager, A. Heimdahl, and C. E. Nord. 1988. Microbial colonization of tumors in relation to the upper gastrointestinal tract in patients with gastric carcinoma. Ann. Surg. 207:341-346.
33. Sugarman, B. J., B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, and H. M. Shepard. 1985. Recombinant human tumor necrosis factor α: effects on proliferation of normal and transformed cells in vitro. Science 230:943-948.
34. Teng, M. N., B. H. Park, H. K. W. Koeppen, K. J. Tracey, B. M. Fendly, and H. Schreiber. 1991. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA 88:3535-3539.
35. Van Mellaert, L., C. Dillen, P. Proost, E. Sablon, R. Deleys, A. Van Broekhoven, H. Heremans, J. Van Damme, H. Eyssen, and J. Anné. 1994. Efficient secretion of biologically active mouse tumor necrosis factor α by Streptomyces lividans. Gene 150:153-158.
36. Van Ostade, X., J. Tavernier, and W. Fiers. 1994. Structure-activity studies of human tumor necrosis factors. Protein Eng. 7:5-22.
37. Wallace, R. B., M. J. Johnson, S. V. Suggs, K. Miyoshi, R. Bhatt, and K. Itakura. 1981. A set of synthetic oligodeoxyribonucleotide primers for DNA sequencing in the plasmid vector pBR322. Gene 16:21-26.
38. Young, M., N. P. Minton, and W. L. Staudenbauer. 1989. Recent advances in the genetics of the clostridia. FEMS Microbiol. Rev. 63:301-326.
39. Zappe, H., W. A. Jones, D. T. Jones, and D. R. Woods. 1988. Structure of an endo-β-1,4-glucanase gene from Clostridium acetobutylicum P262 showing homology with endoglucanase genes from Bacillus spp. Appl. Environ. Microbiol. 54:1289-1292.
40. Zheng, L. X., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351.